Biotech company US Biologic receives USDA licensure for Lyme disease vaccine for mice
US Biologic has received conditional licensure from the USDA for its Lyme disease vaccine for mice, with the product meeting all conditional licensure requirements, including the unique addressing of an emergency condition and the demonstration of safety. The approval allows US Biologic to take the vaccine to market. It comes after the company took years… Read More